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Dysregulated cancer cell
transdifferentiation into erythrocytes
is an additional metabolic stress in
hepatocellular carcinoma
Abigail Hughes and Gurtej K Dhoot
Abstract
A number of human and canine hepatocellular carcinoma tissues showed clear signs of hypoxia indicated by HIF1a-acti-
vation and the presence of large clusters of cells resembling erythrocytes at different stages of nuclear elimination with-
out any defined endothelial cell lining or blood vessel walls. Differentiated erythrocytic identity of such cells in
hepatocellular carcinoma tissues was apparent from their non-nucleated and evolving basophilic to eosinophilic staining
characteristics. In addition to the fully differentiated non-nucleated mesenchymal cell clusters, the onset of erythroblastic
transdifferentiation was apparent from the activation of Glycophorin A, a marker of erythrocytic progenitors, in some
epithelial cancer cells. Activation of canonical Wnt signalling in such tumours was apparent from the expression of Wnt2
ligand and active b-catenin translocation into the nucleus indicating Wnt signalling to be one of the key signalling path-
ways participating in such cell transdifferentiation. Sonic hedgehog and bone morphogenetic protein signalling along with
Sulf1/Sulf2 activation was also observed in such hepatocellular carcinoma tissue samples. The presence of stem cell mar-
kers and the cell signalling pathways associated with erythropoiesis, and the detection of messenger RNAs for both a
and b haemoglobins, support the assumption that hepatocellular carcinoma cells have the potential to undergo cell fate
change despite this process being dysregulated as indicated by the lack of simultaneous generation of endothelial cell lin-
ing. Lack of blood vessel walls or endothelial cell lining around erythrocytic clusters was confirmed by non-detection of
multiple blood vessel markers such as vWF, CD146 and smooth muscle a-actin that were clearly apparent in normal and
unaffected adjacent regions of hepatocellular carcinoma livers. In addition to the activation of Glycophorin A, transdiffer-
entiation of some hepatocellular carcinoma hepatocytes into other cell fates was further confirmed by the activation of
some stem cell markers, for example, NANOG and OCT4 transcription factors, not only by reverse transcription poly-
merase chain reaction but also by their restricted expression in such cells at protein level.
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Introduction
Hepatocellular carcinoma (HCC), a leading cause of
death worldwide,1,2 is characterised by abnormal cell
proliferation requiring adequate supply of oxygen and
nutrients delivered through the blood supply, placing
an unsustainable burden on patient metabolism.3
Many tumours also exhibit a considerable proportion
of necrotic tissue due to dysregulated cell signalling.
This drives unsustainable cell fate or differentiation
options placing an additional metabolic burden on
patient resources. Increasing evidence indicates that
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loss of regulation in cancer cell proliferation leads to
excessive bioenergetic and biosynthetic requirements.4–8
Therefore, it is not surprising that more than half of
cancer patients suffer from cachexia, and nearly 30% of
cancer deaths are a result of anaemia/cachexia rather
than a direct result of tumour growth. Growing
tumours face major metabolic challenges when nutrient
and oxygen requirements outpace the limited supply via
the normal vascular network. This could trigger the sti-
mulation of angiogenesis and/or haemopoiesis to meet
the metabolic demands of increased tumour growth.
The generation of angiogenic and haemopoietic pro-
genitors in an ordered fashion is a highly regulated
growth process in the early embryo and during the
revascularisation of the normal injured regenerating tis-
sues.9 Unlike the normally developing and regenerating
tissues, revascularisation of many rapidly growing
tumours, however, is dysregulated and thus markedly
erratic as vascularisation does not match the rate and
pattern of tumour growth that we found particularly
pronounced in the HCC tissue samples. The cell signal-
ling pathways regulating such cell type generation or
growth play a critical role but are highly dysregulated in
many tumours including HCC.10,11 This together with
unsustainable tumour size and insufficient blood supply
may drive erythrocytic generation without the genera-
tion of endothelial cell lining or lack of pericyte/smooth
muscle cell recruitment essential for blood circulation.
Cancer represents a dysregulated haphazard pattern
of growth characterised by a number of tissue architec-
tural abnormalities. One of the frequent abnormalities
observed in such tissues shows the presence of large
clusters of blood cells, mainly erythrocytes with a small
number of white blood cells, without any sign of blood
vessel wall or endothelial cell lining essential for blood
circulation. Rapid cancer growth promotes angiogen-
esis and vascularisation to meet the demands of
increased blood supply for rapidly growing tissues.
Increased ischaemic stress would also promote haemo-
poiesis in bone marrow or through recruitment of
extramedullary blood supply from spleen under such
conditions. Bone morphogenetic protein (BMP) and
Hedgehog signalling pathways are known to promote
extramedullary haemopoiesis by recruitment of blood
cell progenitors from bone marrow to the spleen before
arriving in the tumour tissue.12 The delivery of blood
Table 1. PCR primers.
Sulf1 P13: 5#-TACCCCCATGTGCTGCCCCT-3#
P14: 5#-GCCGTGGTCGGCGGTGTAAATG-3#
706 bp
Sulf2 P17: 5#-CAACCGCCTTCTCTCTGCTGGGT-3#
P18: 5#-CTGCAGCATGTTGGTGAACTCC-3#
805 bp
HIF1a 257: 5#-CGTTCCTTCGATCAGTTGTC-3#
258: 5#-TCAGTGGTGGCAGTGGTAGT-3#
145 bp
EpoR 295: 5#-CTGGTTTGTCCCTGAAGCCT-3#
296: 5#-GATGGGGCTTACAGGGTGTT-3#
555 bp
Glycophorin A 281: 5#-TCCGGTGTTAACTCTTTCAGGG-3#
282: 5#-CATTGCAGGAGGGTACTCCTTT-3#
401 bp
HBA-a 279: 5#-GGCGGAGAGGCGCTGGACAG-3#
280: 5#-AACGGTACTTGGAGGTCAGC-3#
351 bp
Hb b/d 293: 5#-CTTTGGGGACCTGTCCACTC-3#
294: 5#-GTCCGGGGACCAAATGACTT-3#
354 bp
PDGFRB 325: 5#-GGCCAGAGCTTGTCCTCAAT-3#
326: 5#-AGGGTGCGGTTGTCTTTGAA-3#
955 bp
Vegf a: 5#-GGCAGCTTGAGTTAAACGAAC-3#
b: 5#-ATGGATCCGTATCAGTCTTTCCTGG-3#
130 bp
BMPR2 a: 5#-TGGCAGTGAGGTCACTCAAG-3#
b: 5#-CACGCCTATTGTGTGACAGG-3#
197 bp
ptc1 321: 5#-TTCGGACCGTATCCTGAGGT-3#
322: 5#-TCTCGCACCGGACGTTAAAA-3#
748 bp
Gli1 323: 5#-ATGTGTGTAAGCTCCCTGGC-3#
324: 5#-CCCCTGCATTGGGGTTGTAT-3#
819 bp
Nanog 283: 5#-GAATAACCCGAATTGGAGCAG-3#
284: 5#-AGCGATTCCTCTTCACAGTTG-3#
141 bp
Oct4 285: 5#-ATGTGGTCCGAGTGTGGTTC-3#
286: 5#-GTGGTGACAGACACAGAGGG-3#
241 bp
Bcl2 287: 5#-TGGATGACTGAGTACCTGAA-3#
288: 5#-GGCCTACTGACTTCACTTAT-3#
206 bp
Bax 289: 5#-CGAATGTCTCAAGCGCATCG-3#
290: 5#-TTCCAGATGGTGAGTGACGC-3#
387 bp
b-actin P0: 5#-CTATGAGCTGCCTGACGGTC-3#
P00: 5#-AGTTTCATGGATGCCACAGG-3#
114 bp
PCR: polymerase chain reaction.
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supply from both the bone marrow and/or spleen, how-
ever, is dependent on the establishment of blood vessel
channels that are also essential for transport to and
from the lungs. The lack of well-developed, or even
poorly developed, endothelial lined channels surround-
ing blood clusters, in a number of tumour tissues,
Figure 1. H&E-stained paraffin sections of normal human liver and hepatocellular carcinoma tissues at different stages of disease:
(a) normal (liver sample from a 66-year-old male), (b) HCCI (liver sample from a 42-year-old male), (c) HCCII (liver sample from a
43-year-old male), (d) HCCII (liver sample from a 62-year-old male), (e) and (e1) HCCIII (liver sample from a 63-year-old male), (f)
HCCIII (liver sample from a 38-year-old male) and (g) HCCIII (liver sample from a 55-year-old male). Symbol # indicates areas
showing the presence of a large proportion of non-nucleated cells or death of such cells (##). Areas labelled with symbol # in (d),
(e), (e1), (f) and (g) clearly indicate gradual loss of nuclei as is apparent from the elimination and shrinking nuclear morphology. The
arrangement of these cells without any clear borders also excludes the possibility of these cells resulting from bleeding or through
extramedullary haemopoiesis. Scale bar = 100mM.
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prompted us to hypothesise that such blood cell clus-
ters that were very common in canine HCC samples
did not arrive from the bone marrow or the spleen, but
were a result of in situ cancer stem cell fate change trig-
gered by dysregulated growth associated ischaemia.
The key objective of this study therefore was to deter-
mine if HCC cells in such regions demonstrated any
signs of transdifferentiation into erythrocytes. This was
supported by our observations that not all such ery-
throcytic cells were fully differentiated but included a
number of cells in the process of nuclear exclusion or
necrosis without any defined borders as erythrocytes
normally differentiate and extrude nuclei in bone mar-
row before entering circulation. We therefore investi-
gated if certain regions of cancer tissue exhibited
hypoxia or signs of stem cell fate change to erythrocytic
cell type characteristics. The ischaemic nature of the
cancer tissue was examined by the activation of HIF1a
triggering the activation of the erythropoietin receptor.
The change in stem cell fate of hepatocyte to erythro-
cyte was examined by double immunofluorescence pro-
cedure showing the presence of Glycophorin A, an
erythrocytic progenitor marker, and the presence of a
hepatocytic marker called cytokeratin 18 in the same
cell.13 The generation of erythrocytic clusters in such
HCC regions was further confirmed by activation of
additional known stem cell markers such as NANOG
and OCT4 with Glycophorin A in the same cell.
This study thus demonstrates the presence of a large
number of blood cell clusters without any blood vessel
walls that ultimately undergo apoptosis, resulting from
a change in the hepatocytic cell fate. This was con-
firmed not only by the in situ activation of, for example,
OCT4 and Glycophorin A but also by detection of hae-
moglobin synthesis, the levels of which can be further
modulated by changes in Sulf1/Sulf2 and multiple cell
signalling pathways. The lack of blood vessels around
such erythrocytic cell clusters that leads to premature
apoptosis without benefitting any tissue highlights fur-
ther metabolic stress in such tumours.
Materials and methods
Tissue histology and immunocytochemistry
All canine (50 samples) and feline (10 samples) tumour
tissue sections of formalin-fixed tissues in the age range
of 8–11 years and their clinical history were provided
by the RVC diagnostic laboratory following an RVC
ethical approval. All human HCC tissue arrays (87
samples) were purchased through US Biomax. Unlike
the human tissue arrays, a large majority of the animal
tissue samples were large biopsies often exceeding
2.5 cm in length and width. Some tissue samples also
included two to three biopsies from different regions of
the same liver. All such biopsies included both tumour
and small proportions of unaffected cells in the distant
regions of the same biopsy. Tissue sections for morpho-
logical observations were stained with a standard hae-
matoxylin and eosin stain. Double immunofluorescent
procedure as described previously14 was used to evalu-
ate the cellular phenotypes of normal and 15 HCC tis-
sues. Following commercial antibodies were used for
this analysis: Wnt2 (Prestige)-1/150, active caspase-3
(R&D)-1/100, ptc1 (Millipore)-1/300, p-Smad1,5,8
(Cell signalling)-1/300, HIF1a (Novus)-1/40, EpoR
(Abcam)-1/250, Glycophorin A (Abcam)-1/10,
Cytokeratin 18 (Abcam)-1/300, smooth muscle a-actin
(IA4)-1/400, vWF15 (Dako)-1/200, rabbit anti CD146
Figure 2. A liver sample from normal human (a) and two
HCCIII human liver sample (b) and (c) sections immunostained
for active caspase 3 (red) enzyme and superimposed with
nuclear DAPI (4#,6-diamidino-2-phenylindole) stain (blue) to
determine if certain cells were undergoing active apoptosis. Red
fluorescence shows the presence of active caspase 3. Section
(c1) represents DAPI stain alone for section (c) as nuclear stain
can be seen more clearly without being partly masked by
caspase stain. Scale bar = 100mM.
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Figure 3. (a)–(e) H&E staining of HCC samples from different regions of the same canine patient or different canine (a1)–(d1)
patients that ranged from 8 to 11 years of age (e.g. (a1)–(a3) = patient 2, (b1) and (b2) = patient 3, (c1) and (c2) = patient 4,
(d1) = patient 7 and a feline patient (e1) = patient 9). The numbers 2–9 in the top right-hand corner refer to the patient number used
for molecular analyses in Figures 8 and 9. (f) and (g) Tunnel stain of some such HCC canine liver tissue sections (patients 2 and 3) to
demonstrate apoptosis and or eventual necrosis of such cells. Very clear demonstration of non-nucleated cells not appearing as a
result of bleeding or by extramedullary haemopoiesis is also apparent in (a3) that shows the interdigitation of these cells with the
nucleated cells. Scale bar = 100mM.
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(Sigma)-1/200, mouse anti NANOG (Abcam)-1/100
and rabbit anti OCT4 (Novus biologicals)-1/100. With
the exception of Glycophorin A antibody that itself is
linked to 488 fluorochrome, the binding of all other
antibodies was detected by secondary antibodies linked
to 488 (green) fluorochrome or 594 (red) fluorochrome
as previously described.14 Immunoperoxidase staining
was used to detect the expression pattern of active-b-
catenin (Millipore) antibody using 1/100 dilution as
previously described.16
Figure 4. (a)–(d) HCC liver tissue sections from different patients ((a) = patient 2, (b) = patient 3, (c1) and (c2) = patient 4, (d1) and
(d2) = patient 7) stained with antibody to HIF1a by immunofluorescence. Samples (e) (patient 4) and (f) (patient 7) are stained for
EPOR by immunofluorescence. Scale bar = 100mM.
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Reverse transcription polymerase chain reaction
All 50 canine and feline tumour tissues and normal or
unaffected liver samples for reverse transcription poly-
merase chain reaction (RT PCR) analysis were supplied
by the RVC bio-bank following owner informed con-
sent and RVC ethical approval. All these tissue samples
were used to prepare total RNA using Trizol to gener-
ate complementary DNA (cDNA) with reverse tran-
scriptase as described previously.17,18 Only 10 HCC
tumour biopsies for which we also had detailed immu-
nocytochemical analysis were selected for further RT
PCR analysis. The polymerase chain reaction (PCR) of
Figure 5. (a)–(d) HCC liver tissue sections from different patients ((a1) and (a2) = patient 2, (b1) and (b2) = patient 3, (c1)–
(c3) = patient 4, (d) = patient 7) stained with antibody to Glycophorin A, an erythroid marker by immunofluorescence. Scale
bar = 100mM.
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such samples was carried out using canine/feline pri-
mers listed in Table 1. PCR fragments following 40
amplification cycles were photographed following
separation in 2% agarose gels.
Results
The presence of erythrocyte-like cell clusters in HCC
The normal liver is composed of single-layered hepato-
cyte cords separated by sinusoids (Figure 1(a)). This
highly organised structure is disrupted in HCC-afflicted
livers (Figure 1(b)–(g)) as shown in the H&E-stained
human liver sections. These human HCC livers show
not only the histopathological changes characterising
HCC but also additional changes highlighting the pres-
ence of non-nucleated erythrocyte-like cells without any
endothelial cell lining or blood vessel walls. Such non-
nucleated erythrocyte-like clusters highlighted by sym-
bol # also show the presence of a number of cells with
reduced nuclear stain, indicating the gradual in situ gen-
eration of non-nucleated cells from nucleated basophilic
cells rather than recruitment from the bone marrow.
The non-nucleated eosinophilic clusters of cells (indi-
cated by #) were often surrounded by basophilic cells
(Figure 1(e)). Non-nucleated cell clusters often eventu-
ally led to necrosis (indicated by # #) and thinning out
of solid tumour in some places (Figure 1(c)). Loss of
nuclei and localised apoptosis was also apparent in
some human HCC samples detected by antibody stain-
ing of active caspase 3 (Figure 2). Immunofluorescent
staining with most antibodies also highlighted high lev-
els of erythrocytic autofluorescence at earlier stages that
was reduced during later necrotic stages.
The abundance of non-nucleated cells among HCC
cells was further investigated by H&E staining (Figure
3(a1)–(e1)) of some canine and feline HCC livers and
all further work was restricted to canine and/or feline
tissue samples as we also had some matching fresh tis-
sue samples for RT PCR. The presence of non-
nucleated irregular erythrocyte-like clusters (high-
lighted with symbol #) without any endothelial cell lin-
ing appeared even more apparent in many canine and
Figure 6. The expression of Glycophorin A, an erythroblast marker and cytokeratin 18 associated with HCC tumours is
undetectable in normal and unaffected adjacent regions of canine liver ((a1), (b1) and (c1)) while both Glycophorin A ((b1) and (c1))
and cytokeratin 18 ((b2) and (c2)) at variable levels were detected in the same cells ((b3) and (c3)) in a large proportion of the HCC
tumours undergoing transdifferentiation (detected by double immunofluorescence procedure). Scale bar = 100mM.
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some feline HCC livers. This differed from the erythro-
cytes present in normal blood vessels (*) bounded by
endothelial cell lining (indicated by the arrows in
Figure 3(a1)). A TUNEL (terminal deoxynucleotidyl
transferase (TdT) dUTP nick-end labelling) assay,
which detects DNA fragmentation with TUNEL,
detected the presence of a number of cells undergoing
apoptosis and cell death leading to complete loss of
large clusters of cells in such HCC canine liver samples
(Figure 3(b1), (b2) and (g)).
Evidence of ischaemia in HCC tissues
Since several regions of apoptosis/necrosis, often associ-
ated with non-nucleated erythrocyte-like clusters, were
observed in some human and many canine HCC livers,
we examined if such changes resulted from ischaemia
due to sinusoidal occlusion. This was checked by anti-
body staining for hypoxia-inducible factor 1-alpha
(HIF1a) that is considered to be a master transcrip-
tional regulator of cellular hypoxia. Unlike the normal
liver (not shown), many HCC liver samples showed
variable levels of HIF1a in localised regions. Further
staining of such tissues also showed the presence of the
erythropoietin receptor (EpoR) protein (Figure 4)
known to be expressed only transiently, in localised
regions of HCC but not the normal liver.
Presence of multiple erythrocytic markers in HCC
liver cells without blood vessel markers
The HCC and normal liver tissue sections were also
stained with an antibody to Glycophorin A (an
erythroid-lineage-specific membrane sialoglycoprotein)
to determine if hypoxia or ischaemia induces in situ
generation of erythroid cells in such tissues as indicated
by the presence of many non-nucleated cells.
Glycophorin A is an erythrocytic membrane protein
expressed at all stages of erythroid differentiation that
includes both nucleated and non-nucleated stages of
differentiation. This study detected localised presence
of Gycophorin A only in certain regions of nucleated
HCC liver cells (Figure 5). The transdifferentiation of
HCC hepatocytes into erythrocytes was further indi-
cated by the co-expression of Glycophorin A, an ery-
throid marker, and cytokeratin 18, a hepatocytic
marker, that is also described as an epithelial cancer
stem cell marker, in a subset of cells resembling hepato-
cytic cords in a number of HCC patient samples
(Figure 6).
The HCC hypoxia was further confirmed by RT
PCR analysis of HIF1a and EpoR messenger RNAs
(mRNAs) in such samples as was the presence of a
number of erythrocytic mRNAs detected by RT PCR
in eight canine (1–8) and two feline (9 and 10) HCC liver
samples (Figure 7). Erythrocytic markers analysed by
RT PCR in this study included Glycophorin-A, a-globin
and b/d-globin. Such HCC liver sample analysis also
showed the presence of NANOG and OCT4 stem cell
markers indicating their potential to transdifferentiate
into other cell types such as erythrocytes. Also detected
in these samples was the mRNA for BAX and bcl-2,
pro-apoptotic and anti-apoptotic markers.
The presence in normal liver but absence of blood
vessels around erythrocytic clusters in HCC samples
was confirmed by staining for vWF,15 an endothelial
cell marker and for smooth muscle a-actin, a smooth
muscle cell marker and another blood vessel marker
called CD146 (Figure 8). These antibodies stained
blood vessel lining in normal and unaffected adjacent
regions but not around such cell clusters in HCC tissues
although remnants of some endothelial cell lining (indi-
cated by shrunken irregular cell shapes and small frag-
ments of membranous component) could be detected in
some regions.
Figure 7. The detection of mRNAs representing hypoxia,
erythroblast/erythrocyte markers, stem cell markers and
apoptotic/anti-apoptotic in 10 different canine HCC tissues
using RT PCR analysis. None of the control tissues showed the
expression of any detectable levels of these markers (not
shown).
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Figure 8. Staining of canine HCC patients 2 (a) and (d) and patient 3 (b), (c), (e), (f) livers for vWF (a)–(c) and smooth muscle a-
actin (d)–(f) using immunofluorescence procedure. *Highlights the areas with remnants of erythrocytes without any endothelial
(vWF) or smooth muscle cell lining (smooth muscle a-actin). The presence of blood vessels/sinusoids in an unaffected normal canine
liver (g) compared with non-detection of any blood vessels in HCC canine patient 2 (h) is also apparent from the staining for CD146
antigen regarded as an essential component of blood vessels as it stains endothelial cells. Scale bar = 100mM.
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Activation of multiple cell signalling pathways in HCC
liver tissues
Since Wnt signalling is known to promote erythroid
differentiation, we first examined the expression of
Wnt2 ligand in HCC samples to see if Wnt2 expression
correlated with areas of Glycophorin A expression.
The double immunofluorescence for these two markers
showed close correlation of Glycophorin A expression
with the expression of Wnt2 ligand in nucleated cells of
a number of HCC patients (Figure 9) indicating Wnt
signalling involvement in erythroid specification or dif-
ferentiation. The presence of Wnt signalling indicated
by the detection of Wnt2 ligand in HCC livers was
further examined by the staining for active-b-catenin
translocation into nucleus in such samples. A signifi-
cant proportion of HCC cells in such tissues demon-
strated activated-b-catenin in the nuclei (Figure 10(a)–
(c1)) that is a key downstream transcriptional co-
activator of canonical Wnt signalling. The size of the
activated-b-catenin (brown)-positive nuclei was nearly
twice the size of the unstained blue nuclei of unaffected
cells in such samples. Wnt signalling, however, was not
the only cell-signalling pathway active in such cells.
Immunocytochemical analysis showed the activation of
sonic hedgehog (SHH) signalling, apparent from the
recruitment of its receptor, ptc1, as was the activation
of both Sulf1 and Sulf2 mRNA (Figure 11) that are
Figure 9. Double immunofluorescence staining of different regions of patient 2 (a1)–(a4) and patient 3 (b1–b4) liver samples for
the expression of Glycophorin A (green) and Wnt2 ligand (red) in epithelial-like hepatocytes indicates possible involvement of Wnt
signalling in cellular transdifferentiation. Scale bar = 100mM.
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usually undetectable in the normal adult liver.17,18 The
activation of SHH signalling was also confirmed by the
activation of ptch1 and Gli mRNA using RT PCR
analysis. BMP signalling was also apparent from the
detection of its Smad1,5,8 downstream targets detected
by immunocytochemistry (Figure 10(d) and (e)) as well
as by the detection of BMPR2 mRNA (Figure 10).
Also detected in these HCC tissue samples was the
presence of vascular endothelial growth factor (VEGF)
ligand and PDGFR-B receptor mRNA (Figure 11)
thus showing the activation of multiple cell signalling
pathways.
Activation of stem cell markers in HCC regions
undergoing transdifferentiation
To further confirm cancerous hepatocytic transdifferen-
tiation into erythrocytes and to ascertain the activation
of stem cell markers indicated by RT PCR analysis of
canine HCC samples, this study was further extended
by immunocytochemical analysis of OCT4, NANOG
and CD146. CD146 normally associated with blood
vessels has also been reported to be a stem cell marker
in some cancer tissues. NANOG and OCT4 (Octamer-
binding transcription factor 4) are known to be key
Figure 10. The staining for the expression of active nuclear b-catenin by immunoperoxidase followed by H&E stain is shown at low
magnification (a)–(c) and higher magnification of patient 8 (a) and (a1) and different regions of tissue samples from HCC patient 3 (b),
(b1), (c) and (c1) further indicating the involvement of canonical Wnt signalling. SHH signalling is examined by immunofluorescent
staining for ptc1 (d) while BMP signalling was examined by immunofluorescent staining for Smad 1,5,8 (e). Scale bar = 100mM.
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regulators of embryonic stem cell self-renewal and plur-
ipotency with a potential to re-activation in cancer.
CD146 expression is generally restricted to blood ves-
sels in normal liver (Figure 8(g) and 12(a2)), but its
expression was observed in certain regions of
hepatocyte-like cancer cells (Figure 12(b)–(d)). While
OCT4 and NANOG expression could easily be identi-
fied in embryonic tissues (Figure 12(e) and (f)), these
transcription factors were undetectable in normal unaf-
fected liver (Figure 12(g) and (h)). The expression of
NANOG using this antibody was generally low in the
HCC samples tested (Figure 12(i)), but the nuclear
expression of OCT4 was clearly apparent in a number
of cells in the areas adjacent to erythrocytic clusters
(Figure 12(j)–(l)). The proportion of cells expressing
OCT4 in such samples showed marked regional differ-
ences that ranged from 0% to moderate levels of 5%–
18% but exceeding 95% in some other areas (Figures
12 and 13). The level of OCT4 expression in individual
cells was also variable ranging from barely detectable
levels to high level of expression (Figures 12 and 13).
Level of OCT4 expression did not only vary in the
nucleus but was also observed in the cytoplasm in some
regions as this transcription factor is known to shuttle
between nucleus and cytoplasm.19
Double immunofluorescence procedure confirmed
close correlation of OCT4 and Glycophorin A
expression in the same cell undergoing hepatocytic to
erythrocytic transdifferentiation (Figure 13) although
the levels of both these markers varied during different
stages of such change.
Discussion
HCC, like many other cancers, undergoes marked his-
topathological changes disrupting normal cell function.
However, it was unusual to see large clusters of ery-
throcytes without any endothelial cell lining or blood
vessel walls in a number of HCC tumour tissues. While
the number of such erythrocytic clusters was small in
human tumours, such cells were much more abundant
and apparent in many canine HCC cancers. The ery-
throcytic identity of such cells could easily be ascer-
tained by the absence of nuclei using both general
histological stains and morphological changes observed
by DAPI (4#,6-diamidino-2-phenylindole)-stained nuclei.
Indeed, the presence of large pools of blood containing
differentiated erythrocytes was even apparent by red
haemoglobin in a number of unstained HCC tumour
sections. The generation of such cells could be triggered
by tissue hypoxia,20 a pathophysiologic property of
many cancers that is indicated by the activation of
HIF1a transcription factor in certain regions of most
HCC tissues. Ischaemia is further highlighted by the
detection of EpoR in a number of HCC tissues though
not all since erythropoietin (Epo), a key haemopoietic
cytokine, induced by hypoxia is expressed only transi-
ently but controls erythropoiesis and protects cells from
hypoxic damage.21 Primary role of Epo signalling is thus
to promote proliferation of erythroid progenitor cells
and rescue erythroid progenitors from cell death.
Many tissues and particularly liver also have the
capacity to generate blood cells outside the bone mar-
row not only during normal development but also dur-
ing chronic anaemia or stress22 as is a feature of many
cancer tissues. Erythrocytic cells in these HCC tumours,
however, clearly did not arise by extramedullary hae-
mopoiesis (EH), a process that sometimes is triggered
by stress as a compensatory mechanism. EH requires
blood circulation and thus the presence of blood ves-
sels. The presence of non-nucleated erythrocyte-like cell
clusters at different stages of differentiation without
any evidence of surrounding blood vessels or endothe-
lial cell lining thus raises the question of the origin of
such cells. The alternative explanation therefore is the
transdifferentiation of hepatocytic cancer/stem cells
into erythrocytes as indicated by the appearance of
Glycophorin A in epithelial cells resembling hepatocytic
cords before adopting mesenchymal state. This conclu-
sion was further supported by evidence of localised
hypoxia, its downstream targets and activation of a
number of cell signalling pathways associated with
Figure 11. The detection of different cell signalling components
in 10 different canine HCC tissues using RT PCR analysis. None
of the controls showed the expression of Sulf1/Sulf2 or any
detectable levels of such cell signalling components (not shown).
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Figure 12. The expression of CD146, NANOG and OCT4 proteins was analysed by antibody staining to determine if HCC livers
undergoing transdifferentiation were activating some stem cell markers. CD146 expression in two regions of unaffected control liver
(a1) and (a2) and HCC livers (b–d) from patients 3, 2 and 1 was analysed using immunofluorescence. The activity of antibodies to
OCT4 and NANOG was ascertained by their staining of normal CS18 human embryonic tissue (e and f) that showed no staining of
normal or adjacent canine liver (g and h). Double immunofluorescence staining of patient 3 liver shows much higher expression of
OCT4 in a selected sub-set of cells when compared with NANOG expression (g). OCT4 was always detectable near regions
showing different developmental stages of erythrocytic cluster formation (i–l) in such livers. Scale bar = 100mM.
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erythropoiesis as well as by co-expression of cytokeratin
18 and Glycophorin A in the same cell.
Most cancer tissues show the existence of stem cell
subpopulations that keep the cancer growth going and
often persist following drug treatment. Activation of
stem cell–like characteristics enables such cells to change
cell fate as and if required under hypoxia and associated
stress. The presence of stem cell–like cells in the current
analysis of canine HCC tumours was apparent from the
detection of NANOG and OCT4 transcription factors
that regulate self-renewal and pluripotency.23 Such stem
cells therefore have the potential to undergo erythropoi-
esis and/or angiogenesis. Erythropoiesis is triggered by
hypoxia that these tissues clearly experience and induce
erythropoietin activation as revealed by the detection of
EpoR. The activation of erythrocytic markers in most
canine HCC tumours was apparent using immunocyto-
chemical (Glycophorin A) and RT PCR analyses of
mRNAs for a and b/d haemoglobins. The activation of
erythropoietin has also been proposed to exert anti-
apoptotic effect on haemopoietic cells similar to bcl-2
that was also detected in such HCC samples. The acti-
vation of NANOG and particularly OCT4 in a number
of cells in areas adjacent to erythrocytic clusters and co-
expression with Glycophorin A in the same cell further
confirms the HCC transdifferentiation into erythrocytic
cell fate change before enucleation and cell death of
such cells.
Cell signalling plays a key role not only in cancer
growth and metastasis but also any cell fate changes
that may take place under hypoxia, as the aberrant
blood supply often creates a hypoxic microenvironment
Figure 13. The expression of Glycophorin A and OCT4 is undetectable in normal and adjacent unaffected canine liver (a1–a3) but
both these markers are co-expressed in a large proportion of the HCC livers in many regions. (b1)–(b3) and (c1)–(c3) represent
two different regions of canine patient 2 while (d1–d3) represents HCC liver from canine patient 3. OCT4 transcription factor
shows both nuclear and cytoplasmic expression in these regions of HCC livers (b2, c2 and d2). Scale bar = 100mM.
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within some areas of many tumours. The activation of
multiple cell signalling pathways was observed in most
HCC tumours in this study that could relate to multiple
activities in such cells. VEGF and platelet-derived
growth factor (PDGF) cell signalling was observed in
most HCC tumours as VEGF is known to promote
angiogenesis and both VEGF and PDGF cytokines are
known to regulate the control of blood cell forma-
tion.24 Angiogenesis in such regions, however, was not
observed despite the detection of VEGF. Xue et al.25
have also reported PDGF-BB to promote tumour
growth, angiogenesis and extramedullary haemopoiesis
at least in part through modulation of Epo activation.
Hedgehog identified by Gli1/ptc1 activation and BMP
signalling identified by Smad158/BMPR1 activation is
also known to play multiple roles in tumour growth,
stress erythropoiesis and erythroid differentiation.26,27
Despite the activation of multiple cell signalling
pathways, Wnt signalling was one of the major cell sig-
nalling pathways activated in HCC tissues. A number
of HCCs activating canonical Wnt signalling also
showed the activation of Sulf1/Sulf2 enzymes that are
usually undetectable in normal liver.18 Canonical Wnt
signalling was activated in most canine HCC tissues
showing erythropoiesis in the present study as detected
by the expression of Wnt2 ligand and nuclear b-catenin
translocation. In addition to its role in tumour growth,
canonical Wnt signalling thus could drive hepatoblast
to erythroblast transdifferentiation in such HCCs. Both
Sulf1 and Sulf2 have been shown to promote Wnt sig-
nalling28–30 that further supports the transdifferentia-
tion of hepatoblast to erythroblasts by Wnt signalling.
In conclusion, immunocytochemical and mRNA analy-
sis by RT PCR in this study demonstrates the transdif-
ferentiation of hepatocytic cells into erythrocytes
without the generation of blood vessels for circulation.
It also shows that dysregulated cancer cell adaptation
under stress does not benefit the tumour but imposes
additional unsustainable metabolic demands to com-
pensate for the loss of tumour cells in such regions.
Further in vitro studies would determine if only specific
cancer mutations or whether even some normal hepato-
cytes have the potential to transdifferentiate under
hypoxia and the key signalling pathways that drive
such changes in vivo.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of this
article.
Funding
The author(s) disclosed receipt of the following financial sup-
port for the research, authorship, and/or publication of this
article: Abigail Hughes was supported by BBSRC research
studentship and the RVC funding was used to pay for the
publication of this article.
ORCID iD
Gurtej K Dhoot https://orcid.org/0000-0002-1963-6522
References
1. Mittal S and El-Serag HB. Epidemiology of hepatocellu-
lar carcinoma: consider the population. J Clin Gastroen-
terol 2013; 47: S2–S6.
2. Gill RM, Michael A, Westley L, et al. SULF1/SULF2
splice variants differentially regulate pancreatic tumour
growth progression. Exp Cell Res 2014; 324(2): 157–171.
3. Vander Heiden MG, Cantley LC and Thompson CB.
Understanding the Warburg effect: the metabolic
requirements of cell proliferation. Science 2009;
324(5930): 1029–1033.
4. Warburg OS. On the origin of cancer cells. Science 1956;
123: 309–314.
5. Kroemer G and Pouyssegur J. Tumor cell metabolism:
cancer’s Achilles’ heel. Cancer Cell 2008; 13(6): 472–482.
6. Garber K. Energy deregulation: licensing tumors to
grow. Science 2006; 312(5777): 1158–1159.
7. Gatenby RA and Gillies RJ. Why do cancers have high
aerobic glycolysis? Nat Rev Cancer 2004; 4(11): 891–899.
8. Jones RG and Thompson CB. Tumor suppressors and
cell metabolism: a recipe for cancer growth. Genes Dev
2009; 23(5): 537–548.
9. Lizama CO, Hawkins JS, Schmitt CE, et al. Repression
of arterial genes in hemogenic endothelium is sufficient
for haematopoietic fate acquisition. Nat Commun 2015;
6(7739): 7739.
10. De Rosamel L and Blanc JF. Emerging tyrosine kinase
inhibitors for the treatment of hepatocellular carcinoma.
Expert Opin Emerg Drugs 2017; 22(2): 175–190.
11. Hass HG, Vogel U, Scheurlen M, et al. Gene-expression
analysis identifies specific patterns of dysregulated molecu-
lar pathways and genetic subgroups of human hepatocel-
lular carcinoma. Anticancer Res 2016; 36(10): 5087–5095.
12. Lenox LE, Shi L, Hegde S, et al. Extramedullary erythro-
poiesis in the adult liver requires BMP-4/Smad5-depen-
dent signaling. Exp Hematol 2009; 37(5): 549–558.
13. Ma F, Ebihara Y, Umeda K, et al. Generation of func-
tional erythrocytes from human embryonic stem cell-
derived definitive hematopoiesis. Proc Natl Acad Sci U S
A 2008; 105(35): 13087–13092.
14. Gill RM, Mehra V, Milford E, et al. Short SULF1/SULF2
splice variants predominate in mammary tumours with a
potential to facilitate receptor tyrosine kinase-mediated cell
signalling.Histochem Cell Biol 2016; 146(4): 431–444.
15. Zanetta L, Marcus SG, Vasile J, et al. Expression of von
Willebrand factor, an endothelial cell marker, is up-
regulated by angiogenesis factors: a potential method for
objective assessment of tumor angiogenesis. Int J Cancer
2000; 85(2): 281–288.
16. Zaman G, Staines KA, Farquharson C, et al. Expression
of Sulf1 and Sulf2 in cartilage, bone and endochondral
fracture healing. Histochem Cell Biol 2016; 145(1): 67–79.
16 Tumor Biology
17. Gill RB, Day A, Barstow A, et al. Sulf2 gene is alterna-
tively spliced in mammalian developing and tumour tis-
sues with functional implications. Biochem Biophys Res
Commun 2011; 414(3): 468–473.
18. Gill RB, Day A, Barstow A, et al. Mammalian Sulf1
RNA alternative splicing and its significance to tumour
growth regulation. Tumour Biol 2012; 33(5): 1669–1680.
19. Oka M, Moriyama T, Asally M, et al. Differential role
for transcription factor Oct4 nucleocytoplasmic dynamics
in somatic cell reprogramming and self-renewal of
embryonic stem cells. J Biol Chem 2013; 288(21):
15085–15097.
20. Qi C, Zhang J, Chen X, et al. Hypoxia stimulates neural
stem cell proliferation by increasing HIF1alpha expres-
sion and activating Wnt/beta-catenin signaling. Cell Mol
Biol 2017; 63(7): 12–19.
21. Acs G, Chen M, Xu X, et al. Autocrine erythropoietin
signaling inhibits hypoxia-induced apoptosis in human
breast carcinoma cells. Cancer Lett 2004; 214(2):
243–251.
22. Hudson JB, Murad FM, Kunkel JE, et al. Endoscopic
ultrasound guided fine-needle aspiration of a splenic
hemangioma with extramedullary hematopoiesis. Diagn
Cytopathol 2013; 41(12): 1086–1090.
23. Liang J, Wan M, Zhang Y, et al. Nanog and Oct4 associ-
ate with unique transcriptional repression complexes in
embryonic stem cells. Nat Cell Biol 2008; 10(6): 731–739.
24. Duhrsen U, Martinez T, Vohwinkel G, et al. Effects of
vascular endothelial and platelet-derived growth factor
receptor inhibitors on long-term cultures from normal
human bone marrow. Growth Factors 2001; 19(1): 1–17.
25. Xue Y, Lim S, Yang Y, et al. PDGF-BB modulates
hematopoiesis and tumor angiogenesis by inducing ery-
thropoietin production in stromal cells. Nat Med 2011;
18(1): 100–110.
26. Maegdefrau U, Amann T, Winklmeier A, et al. Bone
morphogenetic protein 4 is induced in hepatocellular car-
cinoma by hypoxia and promotes tumour progression. J
Pathol 2009; 218(4): 520–529.
27. Roy A, Haldar S, Basak NP, et al. Molecular cross talk
between Notch1, Shh and Akt pathways during erythroid
differentiation of K562 and HEL cell lines. Exp Cell Res
2014; 320(1): 69–78.
28. Dhoot GK, Gustafsson MK, Ai X, et al. Regulation of
Wnt signaling and embryo patterning by an extracellular
sulfatase. Science 2001; 293(5535): 1663–1666.
29. Ai X, Do AT, Lozynska O, et al. QSulf1 remodels the 6-
O sulfation states of cell surface heparan sulfate proteo-
glycans to promote Wnt signaling. J Cell Biol 2003;
162(2): 341–351.
30. Nawroth R, Van Zante A, Cervantes S, et al. Extracellu-
lar sulfatases, elements of the Wnt signaling pathway,
positively regulate growth and tumorigenicity of human
pancreatic cancer cells. PLoS ONE 2007; 2(4): e392.
Hughes and Dhoot 17
